novocure-Compared to Estimates, NovoCure (NVCR) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, NovoCure (NVCR) reported revenue of $167.2 million, up 7.8% over the same period last year. EPS came in at -$ 0.33, compared to - $0.28 in the year-ago quarter.The reported revenue represents a surprise of +5.76% over the Zacks Consensus Estimate of$ 158.1 million. With the consensus EPS estimate being -$0.42, the EPS surprise was +21.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...